Well Lead Med Co Ltd (603309) - Total Liabilities

Latest as of September 2025: CN¥960.53 Million CNY ≈ $140.56 Million USD

Based on the latest financial reports, Well Lead Med Co Ltd (603309) has total liabilities worth CN¥960.53 Million CNY (≈ $140.56 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Well Lead Med Co Ltd - Total Liabilities Trend (2011–2024)

This chart illustrates how Well Lead Med Co Ltd's total liabilities have evolved over time, based on quarterly financial data. See Well Lead Med Co Ltd current assets vs equity to evaluate short-term liquidity relative to the company's equity base.

Well Lead Med Co Ltd Competitors by Total Liabilities

The table below lists competitors of Well Lead Med Co Ltd ranked by their total liabilities.

Company Country Total Liabilities
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932
China CN¥347.84 Million
Nantong JiangTian Chemical Co. Ltd.
SHE:300927
China CN¥1.09 Billion
mF International Limited Ordinary Shares
NASDAQ:MFI
USA $21.51 Million
Tianyang Hot Mel
SHG:603330
China CN¥872.42 Million
Zinzino AB Series B
ST:ZZ-B
Sweden Skr1.05 Billion
NetDragon Websoft Holdings Limited
F:3ND
Germany €4.64 Billion
Anglo American PLC
LSE:AAL
UK GBX31.89 Billion
Dayang Enterprise Holdings Bhd
KLSE:5141
Malaysia RM292.78 Million

Liability Composition Analysis (2011–2024)

This chart breaks down Well Lead Med Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Well Lead Med Co Ltd stock valuation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 1.77 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.50 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.33 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Well Lead Med Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Well Lead Med Co Ltd (2011–2024)

The table below shows the annual total liabilities of Well Lead Med Co Ltd from 2011 to 2024.

Year Total Liabilities Change
2024-12-31 CN¥937.61 Million
≈ $137.20 Million
+22.03%
2023-12-31 CN¥768.37 Million
≈ $112.44 Million
+19.34%
2022-12-31 CN¥643.85 Million
≈ $94.22 Million
+19.04%
2021-12-31 CN¥540.87 Million
≈ $79.15 Million
+56.85%
2020-12-31 CN¥344.83 Million
≈ $50.46 Million
-17.77%
2019-12-31 CN¥419.35 Million
≈ $61.36 Million
-11.61%
2018-12-31 CN¥474.41 Million
≈ $69.42 Million
+328.82%
2017-12-31 CN¥110.63 Million
≈ $16.19 Million
+1.15%
2016-12-31 CN¥109.37 Million
≈ $16.00 Million
+6.78%
2015-12-31 CN¥102.43 Million
≈ $14.99 Million
-34.18%
2014-12-31 CN¥155.62 Million
≈ $22.77 Million
-9.07%
2013-12-31 CN¥171.15 Million
≈ $25.04 Million
+7.12%
2012-12-31 CN¥159.77 Million
≈ $23.38 Million
-7.05%
2011-12-31 CN¥171.89 Million
≈ $25.15 Million
--

About Well Lead Med Co Ltd

SHG:603309 China Medical Instruments & Supplies
Market Cap
$483.05 Million
CN¥3.30 Billion CNY
Market Cap Rank
#12418 Global
#3620 in China
Share Price
CN¥11.31
Change (1 day)
-1.82%
52-Week Range
CN¥11.31 - CN¥15.95
All Time High
CN¥33.54
About

Well Lead Medical Co., Ltd. engages in the development, production, and sale of medical devices in urology, endourology, anaesthesia, respiratory, hemodialysis, and pain management areas worldwide. It provides urology products, including Foley catheter, Nelaton catheters, urine collection products, and accessories; endourology products, such as the ClearPetra family system, ureterorenoscope, guid… Read more